Description
CO-1686isaninhibitorofmutantformsofEGFR,includingT790MEGFR.CO-1686exhibitsanticancerchemotherapeuticactivity,inducingtumorregressioninanimalmodelsofnon-smallcelllungcancer(NSCLC)andsensitizingcancercellsinvitrotootherchemotherapeutics.
CO-1686isaninhibitorofmutantformsofEGFR,includingT790MEGFR.CO-1686exhibitsanticancerchemotherapeuticactivity,inducingtumorregressioninanimalmodelsofnon-smallcelllungcancer(NSCLC)andsensitizingcancercellsinvitrotootherchemotherapeutics.
CasNo. | 1374640-70-6 |
---|---|
Purity | ≥98% |
Formula | C27H28F3N7O3 |
FormulaWt. | 555.55 |
ChemicalName | N-(3-((2-((4-(4-Acetylpiperazin-1-yl)-2-methoxyphenyl)amino)-5-(trifluoromethyl)pyrimidin-4-yl)amino)phenyl)prop-2-enamide |
IUPACName | N-[3-[[2-[4-(4-acetylpiperazin-1-yl)-2-methoxyanilino]-5-(trifluoromethyl)pyrimidin-4-yl]amino]phenyl]prop-2-enamide |
Synonym | AVL-301;Rociletinib |
Appearance | Off-whitepowder |
StoreTemp | 4°C |
---|---|
ShipTemp | Ambient |
MSDS | C5600MSDSPDF |
---|---|
InfoSheet | C5600InfoSheetPDF |
WalterAO,SjinRT,HaringsmaHJ,etal.Discoveryofamutant-selectivecovalentinhibitorofEGFRthatovercomesT790M-mediatedresistanceinNSCLC.CancerDiscov.2013Dec;3(12):1404-15.PMID:24065731.
YuHA,RielyGJ.Second-generationepidermalgrowthfactorreceptortyrosinekinaseinhibitorsinlungcancers.JNatlComprCancNetw.2013Feb1;11(2):161-9.PMID:23411383.